cbdMD (YCBD) Total Liabilities (2016 - 2026)
cbdMD (YCBD) posted Total Liabilities of $2.8 million for Q4 2025, down 13.14% sequentially from $3.2 million in Q3 2025, and down 71.58% YoY from $9.8 million in Q4 2024.
cbdMD (YCBD) Total Liabilities (2016 - 2026) Analysis & Trends
cbdMD has reported Total Liabilities for 10 years, with the latest figure at $2.8 million in Q4 2025.
- Quarterly Total Liabilities fell 71.58% year-over-year to $2.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.8 million (down 71.58% YoY) and the FY2025 annual result came in at $3.2 million, down 62.94% from the prior year.
- Total Liabilities retreated to $2.8 million in Q4 2025 per YCBD's latest filing, from $3.2 million in the prior quarter.
- Over five years, Total Liabilities peaked at $35.2 million in Q1 2021 and troughed at $2.8 million in Q4 2025.
- A 5-year average of $11.6 million and a median of $9.6 million in 2022 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2021 and 2025: Total Liabilities surged 72.2% in 2021, then tumbled 71.58% in 2025.
- Over 5 years, Total Liabilities stood at $14.9 million in 2021, then tumbled by 38.79% to $9.1 million in 2022, then slipped by 11.8% to $8.1 million in 2023, then climbed by 21.13% to $9.8 million in 2024, then sank by 71.58% to $2.8 million in 2025.
- According to Business Quant data, Total Liabilities over the past three periods registered $2.8 million, $3.2 million, and $3.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 2.12 Bn |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn | 4.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.93 Mn |
| Dec 31, 2025 | 2.77 Mn |
| Sep 30, 2025 | 3.19 Mn |
| Jun 30, 2025 | 3.78 Mn |
| Mar 31, 2025 | 10.27 Mn |
| Dec 31, 2024 | 9.76 Mn |
| Sep 30, 2024 | 8.62 Mn |
| Jun 30, 2024 | 10.82 Mn |
| Mar 31, 2024 | 11.46 Mn |
| Dec 31, 2023 | 8.06 Mn |
| Sep 30, 2023 | 7.16 Mn |
| Jun 30, 2023 | 7.24 Mn |
| Mar 31, 2023 | 7.90 Mn |
| Dec 31, 2022 | 9.14 Mn |
| Sep 30, 2022 | 9.37 Mn |
| Jun 30, 2022 | 10.54 Mn |
| Mar 31, 2022 | 12.96 Mn |
| Dec 31, 2021 | 14.93 Mn |
| Sep 30, 2021 | 21.74 Mn |
| Jun 30, 2021 | 26.24 Mn |